⌘K

Login Start Free

Home/Filings/4/0001313516-09-000005

4//SEC Filing

McWilliams David 4

Accession 0001313516-09-000005

CIK 0001069308other

View on SEC.gov Company Profile

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 1:09 PM ET

Size

5.8 KB

Accession

0001313516-09-000005

Insider Transaction Report

Form 4

Period: 2009-02-06

Opexa Therapeutics, Inc.opxa

McWilliams David

Director

Transactions

Award
Common Stock Option (right to buy)
2009-02-06+8,000→ 275,668 total
Exercise: $0.47From: 2009-06-30Exp: 2019-02-06→ Common Stock (8,000 underlying)

Footnotes (1)

[F1]For services rendered to Issuer as a director.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Opexa Therapeutics, Inc.

CIK 0001069308

Entity typeother

Related Parties

1

filerCIK 0001303311

Filing Metadata

Form type: 4
Filed: Feb 8, 7:00 PM ET
Accepted: Feb 9, 1:09 PM ET
Size: 5.8 KB

View on SEC.gov